Philip Levin, MD
Emergency Medical Services · Gulfport, MSNPI 1619051877
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $213, 3.4 times the $63 reported in 2019. Among emergency medical services clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$175
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$139
- Johnson & Johnson$120
- Lilly USA, LLC$53
- Abbott$49
- Novo Nordisk$35
- plus $177 from 9 others
What the payments were for
- Speaking & faculty fees$253%
- Food & beverage$72397%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 10 | $175 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $139 |
| Johnson & Johnson | 1 | $120 |
| Lilly USA, LLC | 4 | $53 |
| Abbott | 3 | $49 |
| Novo Nordisk | 2 | $35 |
| Instrumentation Laboratory Company | 1 | $25 |
| Bioventus LLC | 1 | $25 |
| Amgen | 2 | $23 |
| Bayer | 1 | $22 |
| UCB, Inc. | 1 | $21 |
| Pfizer | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$748 in reported general payments places this provider in the 95th percentile of 25 emergency medical services providers in Mississippi.
See all emergency medical services providers in Mississippi →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 28 | $298 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $283 |
| Azithromycin | 58 | $269 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $87 |
Paid to pharmacies, not to this prescriber.
Other emergency medical services in Gulfport
- Max KeelingJackson$10K
- John BrooksJackson$708
- Bobbie WestJackson$701
- Chester ShermerJackson$441
- Amy DavisCorinth$378
- Eric ZoogJackson$364
- Lisa AndersonMadison$330
- Greg TavaiHattiesburg$291
- David JohnsonYazoo City$259
- Melissa RobertsHattiesburg$181
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.